Vanberra Signal

Biogazelle

Curated by Signal

Transcriptomics-based diagnostics and therapeutics, and qPCR software.

Overview

Biogazelle develops transcriptomics-based diagnostics and therapeutics. It offers Qbase, a software for managing qPCR in research laboratories by streamlining normalization, quality control and calibration between runs. Its proprietary platform sequences the entire transcriptome to identify RNA biomarker targets from clinically relevant samples. These biomarkers can be used to then develop qPCR based diagnostic tests. In addition, the company is developing RNA-based cancer therapies that work by silencing long non-coding RNA.

Key facts

Founded
2007
Headquarters
Ghent, Belgium

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Brain Imaging and Neurostimulation systems

    Life Sciences TechnologyBrussels, Belgium
  • Developer of sunglasses with medical applications

    Life Sciences TechnologyVillers le Bouillet, Belgium
  • Developer of neurodiaganostics and sleep monitoring EEG based device

    Life Sciences TechnologyRumst, Belgium

About Biogazelle

What does Biogazelle do?

Biogazelle develops transcriptomics-based diagnostics and therapeutics.

Where is Biogazelle headquartered?

Biogazelle is headquartered in Ghent, Belgium.

When was Biogazelle founded?

Biogazelle was founded in 2007.

Which sector is Biogazelle in?

Biogazelle operates in Life Sciences Technology.

Who are Biogazelle's competitors?

Companies similar to Biogazelle include Imagilys, Lucimed, and BrainRT.